NCT03630757

Brief Summary

Fibromyalgia syndrome (FMS) is among the most difficult diseases that restrict physical functions of patients due to persistent aches,sleep problems,psychological problems and decrease the quality of life. The aim of this study was to investigate the efficacy of manual therapy (MT) in the treatment of FMS patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 2, 2018

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 5, 2018

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 7, 2018

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

August 7, 2018

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 15, 2018

Completed
Last Updated

August 16, 2018

Status Verified

August 1, 2018

Enrollment Period

3 months

First QC Date

August 7, 2018

Last Update Submit

August 14, 2018

Conditions

Keywords

Fibromyalgia syndromeManual TherapiesPain

Outcome Measures

Primary Outcomes (1)

  • Visual Analog Scale

    The VAS pain score was measured to determine the pain level of the patients. The 0-10 cm chart was presented to the patient, with 0 no pain, 0 the most severe pain felt in life 10, 18 and was asked to mark the pain severity. Then the point marked with the millimetric ruler was measured and recorded.

    Baseline, up to 3 weeks

Secondary Outcomes (3)

  • Pittsburgh Quality of Sleep Questionnaire Index

    Baseline, up to 3 weeks

  • Hospital of Anxiety and Depression Scale

    Baseline, up to 3 weeks

  • Fibromyalgia Impact Questionnaire

    Baseline, up to 3 weeks

Study Arms (2)

Treatment

EXPERIMENTAL

While holding the patient's head with the therapist's hands,the cervical spinous processes with the fingertips palpitate to the occipital condyle towards the proximal.Then the fingers of both hands applied pressure to the axis in the space between the occipital condyle and the spinous process

Other: Treatment

Group 2

PLACEBO COMPARATOR

reaching to the feet while sitting together with warming and cooling periods

Other: Treatment

Interventions

In the study group, a total of 15 sessions of a manual therapy program including myofascial release and mobilization techniques were applied for 60-minute session for 3 weeks(5/wk).

Group 2Treatment

Eligibility Criteria

Age30 Years - 50 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Between the ages of 30 and 50
  • No remission during the last 48 months
  • Do not have regular physical activity
  • Have had a daily activity limit of at least 1 day within 30 days

You may not qualify if:

  • Cardiac, renal, hepatic insufficiency
  • Severe physical disability
  • Comorbid conditions (interstitial cystitis, inflammatory diseases)
  • Chronic viral infection
  • Fever
  • Rheumatoid arthritis, herpes lupus
  • Multiple sclerosis, polio, epilepsy
  • Hypertension and hypotension
  • Respiratory deficiencies during treatment
  • Skin lesions
  • Psychiatric disorders
  • Past surgical history

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul Bilgi University

Istanbul, 34440, Turkey (Türkiye)

Location

MeSH Terms

Conditions

FibromyalgiaPain

Interventions

Therapeutics

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • TOMRIS DUYMAZ

    Istanbul Bilgi University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Patients were randomly divided into 2 groups of 20 people. A randomized list is prepared in a computer environment by a statistician for randomization. In this list, the odd numbers for the control group and the MT group were given double numbers. The group identification is printed on sequentially numbered cards placed in sealed envelopes. After enrollment, the numbered envelope was opened by the patient and the blind investigator. For the study group, manual therapy (MT) was given and the home exercise program was given and for the control group only home exercise program was given. In the study group, a total of 15 sessions of a manual therapy program including myofascial release and mobilization techniques were applied for 60-minute session for 3 weeks(5/wk). The treatment program has been implemented by a physiotherapist who specializes in this area.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Asst. Prof. Ph.D.

Study Record Dates

First Submitted

August 7, 2018

First Posted

August 15, 2018

Study Start

January 2, 2018

Primary Completion

April 5, 2018

Study Completion

July 7, 2018

Last Updated

August 16, 2018

Record last verified: 2018-08

Locations